Annual Interest Expense
$1.50 M
+$1.17 M+348.06%
December 31, 2023
Summary
- As of February 7, 2025, ZVRA annual interest expense is $1.50 million, with the most recent change of +$1.17 million (+348.06%) on December 31, 2023.
- During the last 3 years, ZVRA annual interest expense has fallen by -$5.59 million (-78.83%).
- ZVRA annual interest expense is now -79.54% below its all-time high of $7.34 million, reached on December 1, 2017.
Performance
ZVRA Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$2.31 M
+$202.00 K+9.57%
September 30, 2024
Summary
- As of February 7, 2025, ZVRA quarterly interest expense is $2.31 million, with the most recent change of +$202.00 thousand (+9.57%) on September 30, 2024.
- Over the past year, ZVRA quarterly interest expense has increased by +$1.56 million (+205.82%).
- ZVRA quarterly interest expense is now at all-time high.
Performance
ZVRA Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$5.91 M
+$1.95 M+49.05%
September 30, 2024
Summary
- As of February 7, 2025, ZVRA TTM interest expense is $5.91 million, with the most recent change of +$1.95 million (+49.05%) on September 30, 2024.
- Over the past year, ZVRA TTM interest expense has increased by +$4.41 million (+293.94%).
- ZVRA TTM interest expense is now -20.42% below its all-time high of $7.43 million, reached on September 1, 2020.
Performance
ZVRA TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
ZVRA Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +348.1% | +205.8% | +293.9% |
| 3 y3 years | -78.8% | +205.8% | +293.9% |
| 5 y5 years | -78.8% | +205.8% | +293.9% |
ZVRA Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +348.1% | at high | >+9999.0% | at high | >+9999.0% |
| 5 y | 5-year | -78.8% | +348.1% | at high | >+9999.0% | -20.4% | >+9999.0% |
| alltime | all time | -79.5% | +348.1% | at high | >+9999.0% | -20.4% | >+9999.0% |
Zevra Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.31 M(+9.6%) | $5.91 M(+49.1%) |
| Jun 2024 | - | $2.11 M(+187.1%) | $3.97 M(+93.1%) |
| Mar 2024 | - | $735.00 K(-2.8%) | $2.05 M(+36.8%) |
| Dec 2023 | $1.50 M(+348.1%) | $756.00 K(+106.6%) | $1.50 M(+64.0%) |
| Sep 2023 | - | $366.00 K(+85.8%) | $915.00 K(+36.0%) |
| Jun 2023 | - | $197.00 K(+8.2%) | $673.00 K(+31.4%) |
| Mar 2023 | - | $182.00 K(+7.1%) | $512.00 K(+52.8%) |
| Dec 2022 | $335.00 K(-10.9%) | $170.00 K(+37.1%) | $335.00 K(+97.1%) |
| Sep 2022 | - | $124.00 K(+244.4%) | $170.00 K(+226.9%) |
| Jun 2022 | - | $36.00 K(+620.0%) | $52.00 K(+26.8%) |
| Mar 2022 | - | $5000.00(0.0%) | $41.00 K(-89.4%) |
| Dec 2021 | $376.00 K(-94.7%) | - | - |
| Dec 2021 | - | $5000.00(-16.7%) | $385.00 K(-80.7%) |
| Sep 2021 | - | $6000.00(-76.0%) | $1.99 M(-46.6%) |
| Jun 2021 | - | $25.00 K(-92.8%) | $3.73 M(-31.9%) |
| Mar 2021 | - | $349.00 K(-78.3%) | $5.47 M(-23.8%) |
| Dec 2020 | $7.09 M(+8.8%) | $1.61 M(-7.4%) | $7.18 M(-3.4%) |
| Sep 2020 | - | $1.74 M(-1.7%) | $7.43 M(+2.2%) |
| Jun 2020 | - | $1.77 M(-13.8%) | $7.27 M(+3.3%) |
| Mar 2020 | - | $2.05 M(+10.2%) | $7.03 M(+8.0%) |
| Dec 2019 | $6.51 M | $1.86 M(+18.0%) | $6.51 M(+1.7%) |
| Sep 2019 | - | $1.58 M(+2.7%) | $6.40 M(-1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $1.54 M(+0.2%) | $6.52 M(-4.0%) |
| Mar 2019 | - | $1.53 M(-12.5%) | $6.79 M(-4.2%) |
| Dec 2018 | $7.09 M(-3.4%) | $1.75 M(+3.5%) | $7.09 M(-1.1%) |
| Sep 2018 | - | $1.69 M(-6.4%) | $7.17 M(-2.0%) |
| Jun 2018 | - | $1.81 M(-1.3%) | $7.31 M(-0.3%) |
| Mar 2018 | - | $1.83 M(-0.1%) | $7.34 M(+0.0%) |
| Dec 2017 | $7.34 M(+2.9%) | $1.83 M(-0.3%) | $7.34 M(-0.0%) |
| Sep 2017 | - | $1.84 M(+0.3%) | $7.34 M(+0.1%) |
| Jun 2017 | - | $1.83 M(+0.1%) | $7.33 M(-0.5%) |
| Mar 2017 | - | $1.83 M(-0.3%) | $7.37 M(+3.4%) |
| Dec 2016 | $7.13 M(+55.6%) | $1.84 M(+0.3%) | $7.13 M(+10.3%) |
| Sep 2016 | - | $1.83 M(-2.0%) | $6.46 M(+11.5%) |
| Jun 2016 | - | $1.87 M(+17.3%) | $5.80 M(+14.6%) |
| Mar 2016 | - | $1.59 M(+35.7%) | $5.06 M(+10.5%) |
| Dec 2015 | $4.58 M(+68.4%) | $1.17 M(+0.6%) | $4.58 M(+1.4%) |
| Sep 2015 | - | $1.17 M(+3.1%) | $4.51 M(+12.9%) |
| Jun 2015 | - | $1.13 M(+2.0%) | $4.00 M(+7.2%) |
| Mar 2015 | - | $1.11 M(0.0%) | $3.73 M(+37.3%) |
| Dec 2014 | $2.72 M(+58.4%) | $1.11 M(+70.6%) | $2.72 M(+68.9%) |
| Sep 2014 | - | $650.00 K(-24.7%) | $1.61 M(+67.8%) |
| Jun 2014 | - | $863.00 K(+799.0%) | $959.00 K(+899.0%) |
| Mar 2014 | - | $96.00 K | $96.00 K |
| Dec 2013 | $1.72 M | - | - |
FAQ
- What is Zevra Therapeutics annual interest expense?
- What is the all time high annual interest expense for Zevra Therapeutics?
- What is Zevra Therapeutics annual interest expense year-on-year change?
- What is Zevra Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly interest expense year-on-year change?
- What is Zevra Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Zevra Therapeutics?
- What is Zevra Therapeutics TTM interest expense year-on-year change?
What is Zevra Therapeutics annual interest expense?
The current annual interest expense of ZVRA is $1.50 M
What is the all time high annual interest expense for Zevra Therapeutics?
Zevra Therapeutics all-time high annual interest expense is $7.34 M
What is Zevra Therapeutics annual interest expense year-on-year change?
Over the past year, ZVRA annual interest expense has changed by +$1.17 M (+348.06%)
What is Zevra Therapeutics quarterly interest expense?
The current quarterly interest expense of ZVRA is $2.31 M
What is the all time high quarterly interest expense for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly interest expense is $2.31 M
What is Zevra Therapeutics quarterly interest expense year-on-year change?
Over the past year, ZVRA quarterly interest expense has changed by +$1.56 M (+205.82%)
What is Zevra Therapeutics TTM interest expense?
The current TTM interest expense of ZVRA is $5.91 M
What is the all time high TTM interest expense for Zevra Therapeutics?
Zevra Therapeutics all-time high TTM interest expense is $7.43 M
What is Zevra Therapeutics TTM interest expense year-on-year change?
Over the past year, ZVRA TTM interest expense has changed by +$4.41 M (+293.94%)